Preview

Medicine and ecology

Advanced search

COVID-19 pandemic and lung cancer rates in Kazakhstan: a comparative study of pre-pandemic and pandemic periods

https://doi.org/10.59598/ME-2305-6045-2024-111-2-41-47

Abstract

Aim of the study. To assess the impact of the COVID-19 pandemic on the incidence of lung cancer by component analysis.

Materials and methods. The research material was the data of the Ministry of Health of the Republic of Kazakhstan concerning LC (Form 7). To analyze the dynamics of incidence based on the number of cases from 2011 to 2020, a component method was used.

Results and discussion. Analyzing 2011 and 2020, we found a tendency to decrease the incidence of lung cancer (p=0.000). However, comparing 2019 and 2020, we found a sharp decline in the incidence. The overall decrease was −2,220/0000 and depended on changes in the age structure of the population (∑ΔA=+0,340/0000), the risk of getting illness (∑ΔR=−2,520/0000) and the combined effect of the age structure and the risk of getting illness (∑ΔAR=−0,040/0000). The decrease was mainly due to the impact of the risk of getting illness. According to the calculations of the component analysis, 3,856 patients were expected in 2020, but instead the number of patients decreased to 3,375 and this is characterized by a decrease in the number of cases as a result of changes in the risk of getting illness.

Conclusions. The COVID-19 pandemic has significantly reduced the incidence rate of lung cancer in Kazakhstan. Additional analysis and research are needed to understand the full impact and take appropriate measures to combat cancer in a pandemic.

About the Authors

D. B. Yessenbayev
NGO «Central Asian Institute for Medical Research»; Department of Surgical Diseases with courses of Angiosurgery and Plastic Surgery, NС JSC «Astana Medical University»
Kazakhstan

010000, Astana, Almaty str., 13, sq/office 67

010000, Astana, Beibitshilik str., 49A



Zh. B. Telmanova
NGO «Central Asian Institute for Medical Research»
Kazakhstan

010000, Astana, Almaty str., 13, sq/office 67



D. K. Turebaev
NGO «Central Asian Institute for Medical Research»; Department of Surgical Diseases with courses of Angiosurgery and Plastic Surgery, NС JSC «Astana Medical University»
Kazakhstan

010000, Astana, Almaty str., 13, sq/office 67

010000, Astana, Beibitshilik str., 49A



K. T. Adaibayev
NGO «Central Asian Institute for Medical Research»; Department of Surgical Diseases with courses of Angiosurgery and Plastic Surgery, NС JSC «Astana Medical University»
Russian Federation

010000, Astana, Almaty str., 13, sq/office 67

010000, Astana, Beibitshilik str., 49A



A. M. Jexenova
NGO «Central Asian Institute for Medical Research»; Department of Surgical Diseases named after Professor G. V. Tsoi, NС JSC «Astana Medical University»
Kazakhstan

010000, Astana, Almaty str., 13, sq/office 67

010000, Astana, Beibitshilik str., 49A



Z. A. Bilyalova
NGO «Central Asian Institute for Medical Research»
Kazakhstan

010000, Astana, Almaty str., 13, sq/office 67



G. S. Igissinova
Department of Oncology, Asfendiyarov Kazakh National Medical University
Kazakhstan

050012, Almaty, Tole bi str., 94



S. A. Ayaganov
Department of Surgical Disciplines, Higher School of Medicine, NС JSC «Kokshetau University named after Sh. Ualikhanov»
Kazakhstan

020000, Kokshetau, Abay str., 76



S. E. Ibraev
Department of Public Health and Management, NС JSC «Astana Medical University»
Kazakhstan

010000, Astana, Beibitshilik str., 49A



N. S. Igissin
NGO «Central Asian Institute for Medical Research»; Department of Surgical Disciplines, Higher School of Medicine, NС JSC «Kokshetau University named after Sh. Ualikhanov»; Research Institute of Life and Health Sciences, NС JSC «Kokshetau University named after Sh. Ualikhanov»
Kazakhstan

Nurbek Sagynbekuly Igissin 

020000, Kokshetau, Abay str., 76



References

1. Glanc S. Mediko-biologicheskaja statistika. – M.: Praktika, 1998. – 459 s.

2. Dvojrin V. V. Komponentnyj analiz dinamiki zabolevaemosti zlokachestvennymi novoobrazovanijami (metodicheskie rekomendacii) /V. V. Dvojrin, E. M. Aksel'. – M., 1987. – 10 s.

3. Merkov A. M. Sanitarnaja statistika /A. M. Merkov, L. E. Poljakov. – L.: Medicina, 1974. – 384 s.

4. Dinmohamed A. G. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands /A. G. Dinmohamed, O. Visser, R. H. A. Verhoeven //Lancet Oncol. – 2020. – V. 21 (6). – R. 750-751. doi:10.1016/S1470-2045(20)30265-5.

5. Ferlay J. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, 2023, [cited 2023 Aug 4] / J. Ferlay, M. Ervik, F. Lam //https://gco.iarc.fr/today.

6. Kasymjanova G. The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review /G. Kasymjanova, A. Anwar, V. Cohen // Curr. Oncol. – 2021. – V. 28, №6. – P. 4247-4255. doi:10.3390/curroncol28060360.

7. Kortlever T. L. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic / T. L. Kortlever, L. de Jonge, P. H. A. Wisse //Prev. Med. (Baltim). – 2021. – V. 15. – P. 1106643. doi: 10.1016/j.ypmed.2021.106643.

8. Mangone L. The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy /L. Mangone, F. Marinelli, I. Bisceglia //Biology (Basel). – 2023. – V. 12, №3. – P. 390. doi:10.3390/biology12030390.

9. Mitchell H. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland / H. Mitchell, J. Mclean, A. T. Gavin //BMC Cancer. – 2023. – V. 23 (1). – P. 700. doi:10.1186/s12885-02311216-3.

10. Park J. Y. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea /J. Y. Park, Y. J. Lee, T. Kim // BMC Cancer. – 2020. – V. 20 (1). – R. 1040. doi:10.1186/s12885-02007544-3.

11. Rosenbaum L. The Untold Toll - The Pandemic's Effects on Patients without Covid-19 // N. Engl. J. Med. – 2020. – V. 382 (24). – R. 23682371. doi:10.1056/NEJMms2009984.

12. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020 [Internet]. 2020 [cited 2023 Aug 3]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-atthe-media-briefing-on-covid-19---11-march-2020.

13. World Health Organization. COVID-19 weekly epidemiological update. Edition 154 published 3 August 2023, [cited 2023 Aug 3] //https://www.who.int/publications/m/item/weekly-epidemiologicalupdate-on-covid-19---3-august-2023


Review

For citations:


Yessenbayev D.B., Telmanova Zh.B., Turebaev D.K., Adaibayev K.T., Jexenova A.M., Bilyalova Z.A., Igissinova G.S., Ayaganov S.A., Ibraev S.E., Igissin N.S. COVID-19 pandemic and lung cancer rates in Kazakhstan: a comparative study of pre-pandemic and pandemic periods. Medicine and ecology. 2024;(2):41-47. (In Russ.) https://doi.org/10.59598/ME-2305-6045-2024-111-2-41-47

Views: 203


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-6045 (Print)
ISSN 2305-6053 (Online)